Regenxbio Inc (RGNX)
7.87
+0.47
(+6.35%)
USD |
NASDAQ |
Dec 26, 16:00
7.885
+0.02
(+0.19%)
After-Hours: 20:00
Regenxbio Gross Profit (Annual): 53.03M for Dec. 31, 2023
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Catalyst Pharmaceuticals Inc | 346.24M |
| Vertex Pharmaceuticals Inc | 8.607B |
| Sarepta Therapeutics Inc | 1.093B |
| Edgewise Therapeutics Inc | -- |
| Entrada Therapeutics Inc | -- |